Literature DB >> 22926945

Dynamic regulation of cancer stem cells and clinical challenges.

Chao Ni1, Jian Huang.   

Abstract

A small population of cancer cells referred to as cancer stem cells (CSCs) have received particular attention, as they have been revealed to acquire stem cell-like properties and become the main cause of tumor propagation, metastasis and drug resistance. The CSC theory of tumor formation was believed to follow the hierarchical model initially, and therefore many CSC-targeted therapy methods were expected to cure cancer by eradicating CSCs. However, subsequent CSC research has revealed that rather than a distinct entity, the CSC is a dynamic status that can be continually dedifferentiated from progenitor or differentiated cancer cells. Elucidation of this bidirectional transition mechanism would help perfect the CSC theory and be of great value in the development of more effective anti-cancer drugs. Here, we reviewed the mechanisms of reciprocal conversion between non-CSCs and CSCs. Moreover, several approaches of target CSCs and non-CSCs together with unbiased eradication of all cancer cells are also discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926945     DOI: 10.1007/s12094-012-0927-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  63 in total

1.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

2.  Targeting quiescent tumor cells via oxygen and IGF-I supplementation.

Authors:  Alastair H Kyle; Jennifer H E Baker; Andrew I Minchinton
Journal:  Cancer Res       Date:  2011-12-12       Impact factor: 12.701

3.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

4.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Authors:  John M Heddleston; Zhizhong Li; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

Review 5.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

6.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 7.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

8.  IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures.

Authors:  Guozhu Xie; Qiwei Yao; Ying Liu; Shasha Du; Aihua Liu; Zhaoze Guo; Aimin Sun; Jian Ruan; Longhua Chen; Changsheng Ye; Yawei Yuan
Journal:  Int J Oncol       Date:  2011-11-30       Impact factor: 5.650

9.  Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model.

Authors:  Han-Hsin Chang; Bo-Yie Chen; Chia-Yung Wu; Zih-Jay Tsao; Ying-Yu Chen; Chin-Pao Chang; Chi-Rei Yang; David Pei-Cheng Lin
Journal:  J Biomed Sci       Date:  2011-01-18       Impact factor: 8.410

10.  Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells.

Authors:  Chen Yao; Ying Lin; Mei-Sze Chua; Cai-Sheng Ye; Jiong Bi; Wen Li; Yi-Fan Zhu; Shen-Ming Wang
Journal:  Int J Cancer       Date:  2007-11-01       Impact factor: 7.396

View more
  11 in total

Review 1.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

Review 2.  The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.

Authors:  Jun Ye; Dang Wu; Pin Wu; Zhigang Chen; Jian Huang
Journal:  Tumour Biol       Date:  2014-01-14

Review 3.  Chemoquiescence for ideal cancer treatment and prevention: where are we now?

Authors:  Napapan Kangwan; Jong-Min Park; Eun-Hee Kim; Ki Baik Hahm
Journal:  J Cancer Prev       Date:  2014-06

4.  Selected cytokines in patients with pancreatic cancer: a preliminary report.

Authors:  Wojciech Błogowski; Anna Deskur; Marta Budkowska; Daria Sałata; Anna Madej-Michniewicz; Krzysztof Dąbkowski; Barbara Dołęgowska; Teresa Starzyńska
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

Review 5.  Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium.

Authors:  Zhen Sun; Li Wang; Lihua Dong; Xiujie Wang
Journal:  J Cell Mol Med       Date:  2018-05-25       Impact factor: 5.295

6.  Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.

Authors:  Giovanni Sette; Katia Fecchi; Valentina Salvati; Fiorenza Lotti; Emanuela Pilozzi; Enrico Duranti; Mauro Biffoni; Alfredo Pagliuca; Daniela Martinetti; Lorenzo Memeo; Michele Milella; Ruggero De Maria; Adriana Eramo
Journal:  J Exp Clin Cancer Res       Date:  2013-11-16

7.  ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.

Authors:  Dandan Yu; Yali Zhong; Xiaoran Li; Yaqing Li; Xiaoli Li; Jing Cao; Huijie Fan; Yuan Yuan; Zhenyu Ji; Baoping Qiao; Jian-Guo Wen; Mingzhi Zhang; Gunnar Kvalheim; Jahn M Nesland; Zhenhe Suo
Journal:  Oncotarget       Date:  2015-12-15

8.  Stage-specific embryonic antigen: determining expression in canine glioblastoma, melanoma, and mammary cancer cells.

Authors:  Weiming Lin; Jaime F Modiano; Daisuke Ito
Journal:  J Vet Sci       Date:  2017-03-30       Impact factor: 1.672

Review 9.  Exosomes Regulate the Transformation of Cancer Cells in Cancer Stem Cell Homeostasis.

Authors:  Jiasheng Xu; Kaili Liao; Weimin Zhou
Journal:  Stem Cells Int       Date:  2018-09-23       Impact factor: 5.443

Review 10.  Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.

Authors:  Julia López de Andrés; Carmen Griñán-Lisón; Gema Jiménez; Juan Antonio Marchal
Journal:  J Hematol Oncol       Date:  2020-10-15       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.